Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging

Cancer

Volumn 78, Issue 1, 1996, Pages 91-100

  Abraham, Dana C ^a   Jones, Ronald C ^b   Jones, Stephen E ^b   Cheek, J Harold ^b   Peters, George N ^b   Knox, Sally M ^b   Grant, Michael D ^b   Hampe, David W ^b   Savino, Daniel A ^b   Harms, Steven E ^c,d  

^a Baptist Hospital   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

breast; breast neoplasms; chemotherapy; magnetic resonance imaging

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAMMOGRAPHY; MASTECTOMY; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES;

EID: 8944233855     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960701)78:1<91::AID-CNCR14>3.0.CO;2-2     Document Type: Article

References (35)

1. Bonadonna G. Conceptual and practical advances in the management of breast cancer. J Clin Oncol 1989;7:1380-97.
2. Schwartz GF, Cantor RI, Biermann WA. Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast. Arch Surg 1987;122:1430-4.
3. Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap HY, et al. Multimodal treatment of locoregionally advanced breast cancer. Cancer 1983;51:763-8.
4. Hobar PC, Jones RC, Schouten J, Leitch AM, Hendler F. Multimodality Treatment of Locally Advanced Breast Carcinoma. Arch Surg 1988;123:951-5.
5. Lopez MJ, Andriole DP, Kraybill WG, Khojasteh A. Multimodal therapy in locally advanced breast carcinoma. Am J Surg 1990;160:669-75.
6. Haagensen CD. Diseases of the Breast. 2nd ed. Philadelphia: W. B. Saunders Company, 1971.
7. Aisner J, Morris D, Elias EG, Weirnik PH. Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer. Arch Surg 1982;117:882-7.
8. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507-16.
9. Israel L, Breau J, Morere J. Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. Cancer 1986;57:24-8.
10. Maloisel F, Dufour P, Bergerat JP, Herbrecht R, Duclos B, Boilletot A, et al. Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer 1990;65:851-55.
11. Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986; 46:2578-81.
12. Singletary SE, McNeese MD, Hortobagyi GN. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992; 69:2849-52.
13. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP Trials. World J Surg 1994;18:63-9.
14. Bonadonna G, Veronesi U, Brambille C, Ferrari L, Luini A, Greco M, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-45.
15. Mauriac L, Durand M, Avril A, Dilhuydy J-M. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Ann Oncol 1991;2:347-54.
16. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Canton RI, Biermann WA, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.
17. Calais G, Descamps P, Chapet S, Turgeon V, Reynaud-Bougnoux A, LeMarié E, et al. Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers. Int J Radiat Oncol Biol Phys 1993;26:37-42.
18. Calais G, Berger C, Descamps P, Reynaud-Bougnoux A, Body G, et al. Conservative treatment feasibility with induction chemotherapy, surgery and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 1994;74:1283-8.
19. Davis PL, McCarty SK. Technologic considerations for breast tumor size assessment. MRI Clin North Am 1994;2:623-31.
20. Pierce WB, Harms SE, Flamig DP, Griffey RH, Evans WP, Hagans JE, et al. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Radiology 1991; 181:757-63.
21. Cross MJ, Harms SE, Cheek JH, Peters GN, Jones RC. New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging. Am J Surg 1993;166:749-55.
22. Harms SE, Flamig DP. Staging of breast cancer with MR imaging. MRI Clin North Am 1994;2:573-84.
23. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with Rotating Delivery of Excitation Off Resonance: clinical experience with pathologic correlation. Radiology 1993;187:493-501.
24. Swain SM, Sorace RA, Bagley CS, Danforth DN, Bader J, Wesley MN, et al. Neoadjuvant Chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987;47:3889-94.
25. Khanna MM, Mark RJ, Silverstein MJ, Juillard G, Lewinsky B, Guiliano AE. Breast conservation management of breast tumors 4 cm or larger. Arch Surg 1992;127:1038-43.
26. Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169:49-54.
27. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 1995;180:297-306.
28. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. MRI Clin North Am 1994;2:633-58.
29. Gilles R, Guinebretière J, Toussaint C, Spielman M, Rietjens M, Petit J, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-8.
30. Pierce LJ, Lippman M, Ben-Baruch N, Swain S, O'Shaughnessy J, Bader JL, et al. The effect of systemic therapy on local-regional control in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 1992;23:949-60.
31. Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, de Maublanc MA, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990;66:119-29.
32. Ahern V, Barraclough B, Bosch C, Langlands A, Boyages J. Locally advanced breast cancer: defining an optimum treatment regimen. Int J Radiat Oncol Biol Phys 1994;28:867-75.
33. Valagussa P, Zambetti M, Bonadonna G, Zucali R, Mezzanote G, Veronesi U. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat 15:137-47.
34. Perez CA, Fields JN, Fracasso PM, Philpott G, Soares RL, Taylor ME, et al. Management of locally advanced carcinoma of the breast. Cancer 1994;74:466-76.
35. Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien MER, Tidy VA, et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995;13:547-52.